{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T08:37:38Z","timestamp":1786523858844,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52371254"],"award-info":[{"award-number":["52371254"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Program of Science and Technology Development Plan of Jilin Province of China","award":["20260101028JJ"],"award-info":[{"award-number":["20260101028JJ"]}]},{"name":"Beijing Medical and Health Public Welfare Foundation","award":["3D4234975429"],"award-info":[{"award-number":["3D4234975429"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Microchim Acta"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00604-026-08317-8","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T14:31:39Z","timestamp":1785508299000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Harnessing disulfidptosis-ferroptosis synergy to potentiate radiotherapy in triple-negative breast cancer"],"prefix":"10.1007","volume":"193","author":[{"given":"Yan","family":"Geng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengye","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyida","family":"Aishajiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengpeng","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5433-8611","authenticated-orcid":false,"given":"Hongjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"8317_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A (2025) Cancer statistics, 2025. CA Cancer J Clin 75:10\u201345","journal-title":"CA Cancer J Clin"},{"key":"8317_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71:209\u2013249","journal-title":"CA Cancer J Clin"},{"key":"8317_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/srep00227","volume":"2","author":"RM Hallett","year":"2012","unstructured":"Hallett RM, Dvorkin-Gheva A, Bane A, Hassell JA (2012) A gene signature for predicting outcome in patients with basal-like breast cancer. Sci Rep 2:227","journal-title":"Sci Rep"},{"key":"8317_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","volume":"22","author":"L Yin","year":"2020","unstructured":"Yin L, Duan JJ, Bian XW, Yu SC (2020) Triple-negative breast cancer molecular subtyping and treatment progress. Breast Cancer Res 22:61","journal-title":"Breast Cancer Res"},{"key":"8317_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115545","volume":"212","author":"AM Karim","year":"2023","unstructured":"Karim AM, Eun Kwon J, Ali T, Jang J, Ullah I, Lee YG, Park DW, Park J, Jeang JW, Kang SC (2023) Triple-negative breast cancer: epidemiology, molecular mechanisms, and modern vaccine-based treatment strategies. Biochem Pharmacol 212:115545","journal-title":"Biochem Pharmacol"},{"key":"8317_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-020-01501-x","volume":"15","author":"J Haussmann","year":"2020","unstructured":"Haussmann J, Corradini S, Nestle-Kraemling C, B\u00f6lke E, Njanang FJD, Tamaskovics B, Orth K, Ruckhaeberle E, Fehm T, Mohrmann S, Simiantonakis I, Budach W, Matuschek C (2020) Recent advances in radiotherapy of breast cancer. Radiat Oncol 15:71","journal-title":"Radiat Oncol"},{"key":"8317_CR7","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1158\/1078-0432.CCR-13-3229","volume":"21","author":"MA Morgan","year":"2015","unstructured":"Morgan MA, Lawrence TS (2015) Molecular Pathways: Overcoming Radiation Resistance by Targeting DNA Damage Response Pathways. Clin Cancer Res 21:2898\u20132904","journal-title":"Clin Cancer Res"},{"key":"8317_CR8","doi-asserted-by":"publisher","first-page":"13195","DOI":"10.1021\/acsnano.3c00048","volume":"17","author":"L Zeng","year":"2023","unstructured":"Zeng L, Ding S, Cao Y, Li C, Zhao B, Ma Z, Zhou J, Hu Y, Zhang X, Yang Y, Duan G, Bian XW, Tian G (2023) A MOF-Based Potent Ferroptosis Inducer for Enhanced Radiotherapy of Triple Negative Breast Cancer. ACS Nano 17:13195\u201313210","journal-title":"ACS Nano"},{"key":"8317_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","volume":"12","author":"Y Mou","year":"2019","unstructured":"Mou Y, Wang J, Wu J, He D, Zhang C, Duan C, Li B (2019) Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol 12:34","journal-title":"J Hematol Oncol"},{"key":"8317_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201904197","volume":"31","author":"C Liang","year":"2019","unstructured":"Liang C, Zhang X, Yang M, Dong X (2019) Recent progress in ferroptosis inducers for cancer therapy. Adv Mater 31:e1904197","journal-title":"Adv Mater"},{"key":"8317_CR11","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula P, Zhuang L, Gan B (2021) Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell 12:599\u2013620","journal-title":"Protein Cell"},{"key":"8317_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-024-00535-0","volume":"13","author":"J Wang","year":"2024","unstructured":"Wang J, Wang M, Wu S, Zhu Y, Fan K, Chen Y, Xiao Z, Chen J, Tu K, Huang D, Zhang Y, Xu Q (2024) Tumor suppressor BAP1 suppresses disulfidptosis through the regulation of SLC7A11 and NADPH levels. Oncogenesis 13:31","journal-title":"Oncogenesis"},{"key":"8317_CR13","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41556-020-0496-x","volume":"22","author":"X Liu","year":"2020","unstructured":"Liu X, Olszewski K, Zhang Y, Lim EW, Shi J, Zhang X, Zhang J, Lee H, Koppula P, Lei G, Zhuang L, You MJ, Fang B, Li W, Metallo CM, Poyurovsky MV, Gan B (2020) Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer. Nat Cell Biol 22:476\u2013486","journal-title":"Nat Cell Biol"},{"key":"8317_CR14","doi-asserted-by":"publisher","first-page":"19721","DOI":"10.1074\/jbc.M117.814392","volume":"292","author":"T Goji","year":"2017","unstructured":"Goji T, Takahara K, Negishi M, Katoh H (2017) Cystine uptake through the cystine\/glutamate antiporter xCT triggers glioblastoma cell death under glucose deprivation. J Biol Chem 292:19721\u201319732","journal-title":"J Biol Chem"},{"key":"8317_CR15","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41556-023-01091-2","volume":"25","author":"X Liu","year":"2023","unstructured":"Liu X, Nie L, Zhang Y, Yan Y, Wang C, Colic M, Olszewski K, Horbath A, Chen X, Lei G, Mao C, Wu S, Zhuang L, Poyurovsky MV, James You M, Hart T, Billadeau DD, Chen J, Gan B (2023) Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis. Nat Cell Biol 25:404\u2013414","journal-title":"Nat Cell Biol"},{"key":"8317_CR16","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s10495-024-01989-8","volume":"29","author":"F Xiao","year":"2024","unstructured":"Xiao F, Li HL, Yang B, Che H, Xu F, Li G, Zhou CH, Wang S (2024) Disulfidptosis: A new type of cell death. Apoptosis 29:1309\u20131329","journal-title":"Apoptosis"},{"key":"8317_CR17","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1002\/chem.202003523","volume":"27","author":"MJ Neufeld","year":"2021","unstructured":"Neufeld MJ, Lutzke A, Pratx G, Sun C (2021) High-Z Metal-Organic Frameworks for X-ray Radiation-Based Cancer Theranostics. Chemistry 27:3229\u20133237","journal-title":"Chemistry"},{"key":"8317_CR18","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1158\/1535-7163.MCT-12-0131","volume":"11","author":"Y Liu","year":"2012","unstructured":"Liu Y, Cao Y, Zhang W, Bergmeier S, Qian Y, Akbar H, Colvin R, Ding J, Tong L, Wu S, Hines J, Chen X (2012) A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo. Mol Cancer Ther 11:1672\u20131682","journal-title":"Mol Cancer Ther"},{"key":"8317_CR19","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00280-016-3007-9","volume":"77","author":"F Zhao","year":"2016","unstructured":"Zhao F, Ming J, Zhou Y, Fan L (2016) Inhibition of Glut1 by WZB117 sensitizes radioresistant breast cancer cells to irradiation. Cancer Chemother Pharmacol 77:963\u2013972","journal-title":"Cancer Chemother Pharmacol"},{"key":"8317_CR20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nchembio.2079","volume":"12","author":"K Shimada","year":"2016","unstructured":"Shimada K, Skouta R, Kaplan A, Yang WS, Hayano M, Dixon SJ, Brown LM, Valenzuela CA, Wolpaw AJ, Stockwell BR (2016) Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis. Nat Chem Biol 12:497\u2013503","journal-title":"Nat Chem Biol"},{"issue":"11","key":"8317_CR21","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/s41419-021-04306-2","volume":"12","author":"Y Sun","year":"2021","unstructured":"Sun Y, Berleth N, Wu W, Schl\u00fctermann D, Deitersen J, Stuhldreier F, Berning L, Friedrich A, Akg\u00fcn S, Mendiburo MJ, Wesselborg S, Conrad M, Berndt C, Stork B (2021) Fin56-induced ferroptosis is supported by autophagy-mediated GPX4 degradation and functions synergistically with mTOR inhibition to kill bladder cancer cells. Cell Death Dis 12:1028. https:\/\/doi.org\/10.1038\/s41419-021-04306-2","journal-title":"Cell Death Dis"},{"key":"8317_CR22","doi-asserted-by":"publisher","first-page":"19242","DOI":"10.1021\/acsnano.3c05936","volume":"17","author":"S Li","year":"2023","unstructured":"Li S, Xu F, Ren X, Tan L, Fu C, Wu Q, Chen Z, Ren J, Huang Z, Meng X (2023) H(2)S-Reactivating Antitumor Immune Response after Microwave Thermal Therapy for Long-Term Tumor Suppression. ACS Nano 17:19242\u201319253","journal-title":"ACS Nano"},{"key":"8317_CR23","doi-asserted-by":"publisher","first-page":"10601","DOI":"10.1021\/acsami.8b00207","volume":"10","author":"X Zhang","year":"2018","unstructured":"Zhang X, Chen X, Jiang YW, Ma N, Xia LY, Cheng X, Jia HR, Liu P, Gu N, Chen Z, Wu FG (2018) Glutathione-Depleting Gold Nanoclusters for Enhanced Cancer Radiotherapy through Synergistic External and Internal Regulations. ACS Appl Mater Interfaces 10:10601\u201310606","journal-title":"ACS Appl Mater Interfaces"},{"key":"8317_CR24","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.3390\/cancers11091397","volume":"11","author":"M Ricoul","year":"2019","unstructured":"Ricoul M, Gnana Sekaran TS, Brochard P, Herate C, Sabatier L (2019) \u03b3-H2AX foci persistence at chromosome break suggests slow and faithful repair phases restoring chromosome integrity. Cancers (Basel) 11:1397. https:\/\/doi.org\/10.3390\/cancers11091397","journal-title":"Cancers (Basel)"},{"key":"8317_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12645-023-00228-0","volume":"14","author":"N Jackson","year":"2023","unstructured":"Jackson N, Hill I, Alhussan A, Bromma K, Morgan J, Abousaida B, Zahra Y, Mackeyev Y, Beckham W, Herchko S, Krishnan S, Chithrani DB (2023) Dual enhancement in the radiosensitivity of prostate cancer through nanoparticles and chemotherapeutics. Cancer Nanotechnol 14:75","journal-title":"Cancer Nanotechnol"},{"key":"8317_CR26","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1021\/acscentsci.3c00994","volume":"9","author":"Z Wang","year":"2023","unstructured":"Wang Z, Wang D, Ren X, Liu Z, Liu A, Li X, Guan L, Shen Y, Jin S, Zvyagin AV, Yang B, Wang T, Lin Q (2023) One Stone, Three Birds: Multifunctional Nanodots as Pilot Light for Guiding Surgery, Enhanced Radiotherapy, and Brachytherapy of Tumors. ACS Cent Sci 9:1976\u20131988","journal-title":"ACS Cent Sci"},{"key":"8317_CR27","doi-asserted-by":"publisher","first-page":"126567","DOI":"10.1016\/j.seppur.2024.126567","volume":"338","author":"D Wang","year":"2024","unstructured":"Wang D, Wang Z, Ren X, Li Y, Zhang Y, Liang H, Li L, Zhao Y, Jin S, Shen Y, Lin Q, Wang T (2024) A multifunctional bimetallic nanoplatform for enhancing radiotherapy via oxidative damage and ferroptosis of cervical cancer. Sep Purif Technol 338:126567. https:\/\/doi.org\/10.1016\/j.seppur.2024.126567","journal-title":"Sep Purif Technol"},{"key":"8317_CR28","doi-asserted-by":"publisher","first-page":"e2407833","DOI":"10.1002\/advs.202407833","volume":"12","author":"R Aishajiang","year":"2025","unstructured":"Aishajiang R, Liu Z, Liang Y, Du P, Wei Y, Zhuo X, Liu S, Lei P, Wang T, Yu D (2025) Concurrent Amplification of Ferroptosis and Immune System Activation Via Nanomedicine-Mediated Radiosensitization for Triple-Negative Breast Cancer Therapy. Adv Sci (Weinh) 12:e2407833","journal-title":"Adv Sci (Weinh)"},{"key":"8317_CR29","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s12935-022-02801-w","volume":"22","author":"P Bouchalova","year":"2022","unstructured":"Bouchalova P, Bouchal P (2022) Current methods for studying metastatic potential of tumor cells. Cancer Cell Int 22:394","journal-title":"Cancer Cell Int"},{"key":"8317_CR30","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1021\/acsnano.4c15932","volume":"19","author":"Q Li","year":"2025","unstructured":"Li Q, Wu Z, Chen S, Liang Y, Zhu K, Su N, Liu T, Zhao B (2025) Enhancing Ferroptosis-Mediated Radiosensitization via Synergistic Disulfidptosis Induction. ACS Nano 19:1757\u20131770","journal-title":"ACS Nano"},{"key":"8317_CR31","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nrc.2016.77","volume":"16","author":"N Hay","year":"2016","unstructured":"Hay N (2016) Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? Nat Rev Cancer 16:635\u2013649","journal-title":"Nat Rev Cancer"},{"key":"8317_CR32","doi-asserted-by":"publisher","first-page":"6610","DOI":"10.7150\/jca.58500","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang X, Guo Y, Li H, Han L (2021) FIN56, a novel ferroptosis inducer, triggers lysosomal membrane permeabilization in a TFEB-dependent manner in glioblastoma. J Cancer 12:6610\u20136619","journal-title":"J Cancer"},{"key":"8317_CR33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2147\/IJN.S441112","volume":"19","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Song Q, Zhang Y, Xiao J, Deng X, Xing X, Hu H, Zhang Y (2024) Iron-Based Nanovehicle Delivering Fin56 for Hyperthermia-Boosted Ferroptosis Therapy Against Osteosarcoma. Int J Nanomed 19:91\u2013107","journal-title":"Int J Nanomed"},{"key":"8317_CR34","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1038\/s41467-023-39401-9","volume":"14","author":"Y Yan","year":"2023","unstructured":"Yan Y, Teng H, Hang Q, Kondiparthi L, Lei G, Horbath A, Liu X, Mao C, Wu S, Zhuang L, James You M, Poyurovsky MV, Ma L, Olszewski K, Gan B (2023) SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells. Nat Commun 14:3673","journal-title":"Nat Commun"},{"key":"8317_CR35","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","volume":"17","author":"X Chen","year":"2021","unstructured":"Chen X, Li J, Kang R, Klionsky DJ, Tang D (2021) Ferroptosis: machinery and regulation. Autophagy 17:2054\u20132081","journal-title":"Autophagy"},{"key":"8317_CR36","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gasc\u00f3n S, Hatzios SK, Kagan VE, Noel K, Jiang X, Linkermann A, Murphy ME, Overholtzer M, Oyagi A, Pagnussat GC, Park J, Ran Q, Rosenfeld CS, Salnikow K, Tang D, Torti FM, Torti SV, Toyokuni S, Woerpel KA, Zhang DD (2017) Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease. Cell 171:273\u2013285","journal-title":"Cell"},{"key":"8317_CR37","doi-asserted-by":"publisher","first-page":"6013","DOI":"10.1039\/D0CS00718H","volume":"50","author":"Y Xiong","year":"2021","unstructured":"Xiong Y, Xiao C, Li Z, Yang X (2021) Engineering nanomedicine for glutathione depletion-augmented cancer therapy. Chem Soc Rev 50:6013\u20136041","journal-title":"Chem Soc Rev"},{"key":"8317_CR38","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s00204-023-03476-6","volume":"97","author":"B Wang","year":"2023","unstructured":"Wang B, Wang Y, Zhang J, Hu C, Jiang J, Li Y, Peng Z (2023) ROS-induced lipid peroxidation modulates cell death outcome: mechanisms behind apoptosis, autophagy, and ferroptosis. Arch Toxicol 97:1439\u20131451","journal-title":"Arch Toxicol"},{"key":"8317_CR39","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1038\/s41418-021-00859-z","volume":"28","author":"X Chen","year":"2021","unstructured":"Chen X, Kang R, Kroemer G, Tang D (2021) Organelle-specific regulation of ferroptosis. Cell Death Differ 28:2843\u20132856","journal-title":"Cell Death Differ"},{"key":"8317_CR40","doi-asserted-by":"publisher","first-page":"917","DOI":"10.14336\/AD.2024.0083","volume":"16","author":"Q Gu","year":"2024","unstructured":"Gu Q, An Y, Xu M, Huang X, Chen X, Li X, Shan H, Zhang M (2024) Disulfidptosis, A Novel Cell Death Pathway: Molecular Landscape and Therapeutic Implications. Aging Dis 16:917\u2013945","journal-title":"Aging Dis"},{"key":"8317_CR41","doi-asserted-by":"publisher","first-page":"483","DOI":"10.7150\/thno.79625","volume":"13","author":"Z Jiang","year":"2023","unstructured":"Jiang Z, Zhang M, Li P, Wang Y, Fu Q (2023) Nanomaterial-based CT contrast agents and their applications in image-guided therapy. Theranostics 13:483\u2013509","journal-title":"Theranostics"},{"key":"8317_CR42","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cca.2019.01.011","volume":"491","author":"SS Menon","year":"2019","unstructured":"Menon SS, Guruvayoorappan C, Sakthivel KM, Rasmi RR (2019) Ki-67 protein as a tumour proliferation marker. Clin Chim Acta 491:39\u201345","journal-title":"Clin Chim Acta"}],"container-title":["Microchimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00604-026-08317-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00604-026-08317-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00604-026-08317-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T08:16:54Z","timestamp":1786522614000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00604-026-08317-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["8317"],"URL":"https:\/\/doi.org\/10.1007\/s00604-026-08317-8","relation":{},"ISSN":["0026-3672","1436-5073"],"issn-type":[{"value":"0026-3672","type":"print"},{"value":"1436-5073","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"assertion":[{"value":"15 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"586"}}